Voyager Therapeutics Inc (VYGR)
6.22
-0.47
(-7.03%)
USD |
NASDAQ |
Nov 14, 16:00
6.22
0.00 (0.00%)
Pre-Market: 08:09
Voyager Therapeutics Cash from Financing (Quarterly): 0.571M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.571M |
| March 31, 2024 | 112.86M |
| December 31, 2023 | 0.46M |
| September 30, 2023 | 0.331M |
| June 30, 2023 | 1.548M |
| March 31, 2023 | 31.31M |
| December 31, 2022 | 0.276M |
| September 30, 2022 | 0.015M |
| June 30, 2022 | 0.807M |
| March 31, 2022 | 0.012M |
| December 31, 2021 | 0.227M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.357M |
| March 31, 2021 | 0.028M |
| December 31, 2020 | 0.486M |
| September 30, 2020 | 0.51M |
| June 30, 2020 | 2.133M |
| March 31, 2020 | 0.034M |
| December 31, 2019 | 0.30M |
| Date | Value |
|---|---|
| September 30, 2019 | 1.724M |
| June 30, 2019 | 1.069M |
| March 31, 2019 | 77.90M |
| December 31, 2018 | 0.435M |
| September 30, 2018 | 1.368M |
| June 30, 2018 | 1.117M |
| March 31, 2018 | 1.829M |
| December 31, 2017 | 58.26M |
| September 30, 2017 | 0.556M |
| June 30, 2017 | 0.498M |
| March 31, 2017 | 0.602M |
| December 31, 2016 | 0.368M |
| September 30, 2016 | 0.053M |
| June 30, 2016 | 0.089M |
| March 31, 2016 | 0.004M |
| December 31, 2015 | 73.91M |
| September 30, 2015 | -0.952M |
| June 30, 2015 | 59.84M |
| March 31, 2015 | 44.94M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2021
112.86M
Maximum
Mar 2024
8.014M
Average
0.357M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Rhythm Pharmaceuticals Inc | 2.492M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | 5.991M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.58M |
| Cash from Investing (Quarterly) | -35.94M |
| Free Cash Flow | -22.27M |
| Free Cash Flow Per Share (Quarterly) | -0.5639 |
| Free Cash Flow to Equity (Quarterly) | -32.55M |
| Free Cash Flow to Firm (Quarterly) | -32.55M |
| Free Cash Flow Yield | -6.85% |